temazepam 30 mg

INDICATIONS & USAGE Temazepam Capsules, USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Temazepam Capsules should be used for short periods of time (7 to 10 days). The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.

REMEDYREPACK INC.

FDA Reported Adverse Reactions
`[1] off label use` `[2] drug ineffective` `[3] fatigue` `[4] toxicity to various agents` `[5] nausea` `[6] pain` `[7] pyrexia` `[8] diarrhoea` `[9] headache` `[10] dyspnoea`

9 months ago

CAPSULE WHITE 30 mg Novel 123

HOW SUPPLIED Temazepam capsules USP 22.5 mg Light blue opaque cap and white opaque body, imprinted “22.5 mg” on cap and “Novel 122” on the body in black ink. NDC: 70518-2008-00 PACKAGING: 30 in 1 BOTTLE PLASTIC Dispense in a well-closed, light-resistant container with a child-resistant closure. Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Repackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

More pills like CAPSULE 30 mg Novel 123

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

temazepam 30 mg

FDA Reported Adverse Reactions [1] off label use [2] drug ineffective [3] fatigue [4] toxicity to various agents [5] nausea [6] pain [7] pyrexia [8] diarrhoea [9] headache [10] dyspnoea

CAPSULE WHITE 30 mg Novel 123

More pills like CAPSULE 30 mg Novel 123

FDA Reported Adverse Reactions
`[1] off label use` `[2] drug ineffective` `[3] fatigue` `[4] toxicity to various agents` `[5] nausea` `[6] pain` `[7] pyrexia` `[8] diarrhoea` `[9] headache` `[10] dyspnoea`